Evidence map›Paper›PMID 41857098›Full record

ArticleScientific reports2026

A robust mouse liver organoid platform enables sustained multicellular maturation and fibrosis modeling from a single tissue sample.

Yingyu Liang, Yongqin Ye, Hua Xie, Vincent Chi Hang Lui, Yan Chen, Paul Kwong Hang Tam

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yingyu Liang *School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, 999078, China.
Yongqin Ye *Faculty of Medicine, Macau University of Science and Technology, Macau, 999078, China.
Hua XieDepartment of Pediatric Surgery, Children's Hospital of Nanjing Medical University, Nanjing, 210093, China.
Vincent Chi Hang LuiDepartment of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
Yan ChenFaculty of Medicine, Macau University of Science and Technology, Macau, 999078, China. chenyan@must.edu.mo.
Paul Kwong Hang TamSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau, 999078, China. pkhtam@must.edu.mo.

Funding

Macau Science and Technology Development Fund 0086/2022/AMacau Science and Technology Development Fund 0097/2022/A2
6 · The paper itself

Abstract

Efficient isolation and culture of liver organoids are critical for studying liver fibrosis, liver regeneration and drug toxicity and screening. However, preserving mature hepatobiliary characteristics and concurrently incorporating fibrosis-producing hepatic stellate cells (HSCs) remains a significant challenge, often hindering the large-scale production of organoids capable of replicating key liver functions. Here, we report a robust 3D organoid culture system that enables simultaneous isolation and long-term propagation of primary hepatocytes, cholangiocytes, and HSCs from a single source of mouse liver tissue. By supplementing the Hep-Med with Notch signaling inhibitor and dexamethasone, we achieved sustained organoid maturity, including stable albumin production, metabolic activity, and liver-specific gene expression, over multiple passages in culture. Quiescent HSCs within the system retained lipid droplets and could be activated into a myofibroblast-like phenotype, also called activated HSCs, via TGFβ stimulation. Activated HSCs impaired the proliferation and stemness, and induced epithelial-mesenchymal transition (EMT) of Hep-Orgs and Cho-Orgs, enabling in vitro liver fibrosis modeling. Optimized for minimal tissue input, this platform maximizes tissue utilization efficiency while preserving the liver's heterogeneous cellular architecture. Its versatility supports diverse applications in liver disease modeling, drug discovery, and regenerative medicine.

Indexed as

LiverLiver CirrhosisOrganoidsAnimalsEpithelial-Mesenchymal TransitionHepatic Stellate CellsHepatocytesMiceA single liver tissueHepatic stellate cellLiver fibrosis modelingLiver organoid platform

Identifiers

PMID41857098
PMCPMC13136479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.